[Effect of clarithromycin on pathogenic factors in Helicobacter pylori].
Nohata
Kazuo
K
Ota
Michio
M
Hasegawa
Tadao
T
Tsuzuki
Tomoyuki
T
Ando
Takafumi
T
Ina
Kenji
K
Kusukami
Kazuo
K
D018829:Adhesins, Bacterial / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000917:Antibody Formation; D001426:Bacterial Proteins; D017291:Clarithromycin / Q000494:pharmacology* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005407:Flagella / Q000502:physiology / Q000648:ultrastructure; D005753:Gastric Mucosa / Q000166:cytology / Q000382:microbiology; D005756:Gastritis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D006360:Heat-Shock Proteins / Q000276:immunology; D016481:Helicobacter Infections; D016480:Helicobacter pylori / Q000201:enzymology / Q000472:pathogenicity* / Q000648:ultrastructure; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D009068:Movement / Q000187:drug effects; D014510:Urease / Q000378:metabolism
D018829:Adhesins, Bacterial; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D006360:Heat-Shock Proteins; C112564:HspB protein, Helicobacter pylori; D007074:Immunoglobulin G; D014510:Urease; D017291:Clarithromycin